Previous Article | Next Article ![]()
Journal of Clinical Microbiology, September 2005, p. 4840-4843, Vol. 43, No. 9
0095-1137/05/$08.00+0 doi:10.1128/JCM.43.9.4840-4843.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Unité d'Epidémiologie et Physiopathologie des Virus Oncogènes, Département Ecosystèmes et Epidémiologie des Maladies Infectieuses, Institut Pasteur, Paris, France,1 Institut Pasteur de Bangui, Bangui, Central African Republic,2 Laboratoire de Génétique Humaine des Maladies Infectieuses, INSERM U.550, Faculté de Médecine Necker, Paris, France,3 Laboratoire d'Anatomo-pathologie, Hopital Saint-Louis, Paris, France,4 Centre National Hospitalier Universitaire de Bangui, Bangui, Central African Republic,5 Hopital Communautaire de Bangui, Bangui, Central African Republic,6 Unité de Recherche et d'Expertise Histotechnologie et Pathologie, Institut Pasteur, Paris, France7
Received 9 March 2005/ Returned for modification 18 April 2005/ Accepted 13 June 2005
Epidemic Kaposi's sarcoma (KS) is one of the most frequent types of cancer in several African countries; however, very few data are available on human herpesvirus 8 (HHV-8) markers in KS patients from Central Africa. In a series of 36 AIDS-KS cases from Central African Republic, we showed, using a real-time PCR quantitative assay, the high frequency (82%) of detectable HHV-8 DNA in peripheral blood mononuclear cells (PBMCs). We also found that the level of antibodies directed against lytic or latent HHV-8 antigens is not correlated to the amount of HHV-8 viral load in the PBMCs, and finally, we demonstrated a much higher viral load in tumoral skin lesions (6.07 log copies/µg DNA) than in unaffected skin (2.93 log copies/µg DNA) or in PBMCs (2.55 log copies/µg DNA).
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»